Are Integra Essentia Ltd latest results good or bad?

Jan 11 2026 07:11 PM IST
share
Share Via
Integra Essentia Ltd's latest Q3 FY26 results show strong sales growth of 12.37% year-on-year, but profitability remains a concern with low operating margins and reliance on non-operating income, raising questions about long-term sustainability. Overall, the financial health indicates significant challenges despite the sales increase.
Integra Essentia Ltd's latest financial results for Q3 FY26 present a mixed picture. The company reported net sales of ₹140.05 crores, marking a 12.37% increase year-on-year, which is notable as it represents the highest quarterly sales in its recent history. However, this topline growth is overshadowed by concerns regarding operational efficiency and profitability.

The operating margin for the quarter was recorded at 1.66%, reflecting a slight contraction from the previous quarter. This indicates that despite the growth in sales, the company's ability to translate revenue into profit remains limited. Furthermore, the net profit stood at ₹1.24 crores, showing no growth compared to the same quarter last year, which raises questions about the sustainability of its earnings.

A significant aspect of the financials is the heavy reliance on non-operating income, which constituted 76.56% of profit before tax. This dependency suggests that the core business operations are not generating sufficient profits, which could pose risks for future earnings stability. Additionally, the average return on equity (ROE) of 6.18% highlights challenges in capital efficiency, as it falls short of industry benchmarks.

The company's financial position also reveals liquidity concerns, with cash and cash equivalents at a minimal level, indicating limited capacity to navigate operational challenges. The shareholding structure shows a lack of institutional interest, which may further impact investor confidence.

Overall, while Integra Essentia Ltd has achieved notable sales growth, the underlying operational metrics and financial health indicate significant challenges that could affect its long-term viability. The company saw an adjustment in its evaluation, reflecting these ongoing concerns.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News